Key Summary Points {#FPar1}
==================

**Why carry out this study?**Similar to diabetes mellitus, obstructive sleep apnea (OSA) is also known to be a risk factor for cardiovascular diseases.However, no study has yet systematically assessed the cardiovascular outcomes in patients with co-existing diabetes mellitus and OSA following coronary angioplasty.**What was learned from the study?**OSA was associated with a significant increase in all-cause mortality and major adverse cardiac events post coronary intervention in these patients with diabetes mellitus.Therefore, special care and continuous follow-up might be required for patients with diabetes mellitus with associated OSA following percutaneous coronary intervention.

Introduction {#Sec1}
============

It is well known that type 2 diabetes mellitus (T2DM) is a major risk factor for the occurrence of cardiovascular diseases \[[@CR1]\]. Similar to T2DM, obstructive sleep apnea (OSA) \[[@CR2]\], characterized by recurrent partial or complete upper airway obstruction causing hypoxia and arousal from sleep, is also known to be a risk factor for cardiovascular diseases \[[@CR3]\]. Several studies have already shown T2DM to be associated with worse cardiovascular outcomes following percutaneous coronary intervention (PCI) \[[@CR4]\]. Recent studies have also shown that in those patients with acute coronary syndrome (ACS), OSA is associated with a higher risk of short- and long-term cardiovascular events compared to those patients without OSA \[[@CR5]\]. However, no study has yet systematically assessed the cardiovascular outcomes in patients with co-existing T2DM and OSA following coronary angioplasty. In this analysis, we aimed to systematically compare the post-interventional cardiovascular outcomes observed in patients with T2DM with versus without OSA.

Methods {#Sec2}
=======

Data Sources {#Sec3}
------------

The following search databases were explored for relevant publications:MEDLINECochrane Central<https://www.ClinicalTrials.gov>EMBASEWeb of ScienceGoogle Scholar

Searched Terms and Search Strategies {#Sec4}
------------------------------------

The aforementioned databases were searched for relevant publications comparing the cardiovascular outcomes in patients with T2DM with versus without OSA following PCI by using the following search terms:Obstructive sleep apnea, diabetes mellitus, percutaneous coronary interventionObstructive sleep apnea and percutaneous coronary interventionObstructive sleep apnea, type 2 diabetes mellitus, percutaneous coronary interventionObstructive sleep apnea, diabetes mellitus, coronary angioplastyObstructive sleep apnea, diabetes mellitus, coronary revascularizationObstructive sleep apnea, coronary angioplastyObstructive sleep apnea, diabetes mellitus, PCI

Only studies published in English language were considered relevant to this research.

Inclusion and Exclusion Criteria {#Sec5}
--------------------------------

Criteria for inclusion were:Patients with T2DM with OSA who have undergone PCI.Post-PCI cardiovascular outcomes were reported.English publications.

Criteria for exclusion:Patients with T2DM without OSA.Post-interventional cardiovascular outcomes were not reported.Repeated studies.Non-English publications.Literature reviews, meta-analyses and systematic reviews as well as case studies.

Outcomes {#Sec6}
--------

The outcomes assessed in this analysis were:Major adverse cerebrovascular and cardiac events (MACCEs), defined as the total number of deaths, re-infarction, revascularization, and strokeMajor adverse cardiac events (MACEs), defined as the total number of deaths, re-infarction, and revascularizationCardiac deathAll-cause mortalityRe-infarctionStrokeTarget vessel revascularization (TVR)Target lesion revascularization (TLR)Hospitalization for heart failure.

All patients were revascularized by PCI. The outcomes reported in the original studies are listed in Table [1](#Tab1){ref-type="table"}.Table 1Outcomes reported in these patients with type 2 diabetes mellitusStudiesOutcomes reportedApproximate mean follow-up time periodTreatment strategyFan \[[@CR8]\]MACCE, cardiovascular death, MI, stroke, hospitalization for unstable angina, hospitalization for heart failure, all-cause mortality, TVR, TLR1 yearPCI or CABGLee \[[@CR9]\]Death, re-infarction, stroke, TVR, admission due to heart failure, major adverse events18 monthsPCILee \[[@CR10]\]MI, stroke, revascularization, stent thrombosis, MACCE, cardiovascular death, all-cause mortality1.9 yearsPCILoo \[[@CR11]\]MI, revascularization, stroke, hospitalization for heart failure, cardiac death, MACCE24 monthsPCIMeng \[[@CR12]\]MACEs, cardiac death, heart failure, TVR, stroke1 yearPCINakashima \[[@CR13]\]TVR, re-infarction, MACEs4 yearsPCIWu \[[@CR14]\]Revascularization, TLR, TVR, MI, stroke, death, MACE, MACCE1 and 5 yearsPCIYumino \[[@CR15]\]TVR, cardiac death, MACEs8 monthsPCI*MACCEs* major adverse cardiovascular and cerebrovascular events, *MACEs* major adverse cardiac events, *MI* myocardial infarction, *TVR* target vessel revascularization, *TLR* target lesion revascularization, *PCI* percutaneous coronary intervention, *CABG* coronary artery bypass grafting

The mean follow-up time period ranged between 1 and 5 years.

Data Extraction and Quality Assessment {#Sec7}
--------------------------------------

Data were extracted by four independent authors. First of all the first authors' names, the publication year, the total number of participants with T2DM, the total number of participants with T2DM with versus without OSA, the baseline characteristics including the mean age of the participants, the percentage of male patients, the percentage of participants with T2DM who were current smokers, who had hypertension, and those who had dyslipidemia were all carefully extracted. In addition, the type of study, the type of revascularization procedures, the time period of patients' enrollment, the cardiovascular outcomes reported in the original studies, and the corresponding follow-up time period were all carefully extracted.

If any of the authors disagreed about the inclusion of certain data or had any difficulty in the data extraction process, the issues were carefully discussed among all the authors, and then a final decision was made by the corresponding author.

The methodological quality of the studies was assessed by the Newcastle Ottawa Scale (NOS) \[[@CR6]\]. Grades were allotted to the studies to denote low (A), moderate (B), or high risk (C) of bias.

Statistical Analysis {#Sec8}
--------------------

The RevMan software 5.3 was used to carry out the statistical analysis. Odds ratios (OR) with 95% confidence intervals (CI) were used to represent the results following data assessment. There were two ways to assess heterogeneity: (1) using the*Q* statistic test whereby a *P* value less than or equal to 0.05 was considered statistically significant; (2) the *I*^2^ test whereby heterogeneity was increased with an increasing *I*^2^ value. An *I*^2^ value with a low percentage denoted low heterogeneity whereas an*I*^2^ value with a high percentage denoted increased heterogeneity.

A fixed statistical effect was used during data analysis if the heterogeneity was low; however, a random statistical effect model was used in case of high heterogeneity.

Sensitivity analysis was also carried out to prove that the main results were not influenced by any of the studies. In addition, a funnel plot was generated to visually assess publication bias.

Compliance with Ethical Guidelines {#Sec9}
----------------------------------

This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.

Results {#Sec10}
=======

Search Outcomes {#Sec11}
---------------

The Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline was followed \[[@CR7]\]. A thorough search through the electronic databases resulted in a total of 1080 publications. After an assessment of the titles and abstracts by the authors, 988 publications were eliminated and the remaining 92 full-text publications were assessed for eligibility.

Full-text articles were eliminated on the basis of the following criteria:Involved participants did not undergo PCI (*n* = 7).Post-interventional outcomes were not reported (*n* = 3).Non-English publications (*n* = 4).Case studies (*n* = 6).Literature review (*n* = 1).Systematic reviews and meta-analyses (*n* = 3).Repeated studies (*n* = 60).

Finally only eight studies \[[@CR8]--[@CR9]\] were included in this analysis as shown in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flow diagram representing the selection of studies to be included in this analysis

Main and Baseline Features {#Sec12}
--------------------------

Table [2](#Tab2){ref-type="table"} shows the main characteristics of the studies included in this analysis. The time period of patients' enrollment varied from year 2002 to 2017. A total of 1168 participants with T2DM were included in this analysis, of whom 614 had co-existing OSA.Table 2Main features of the studiesStudiesType of studyYear of participants' enrollmentNo. of patients with T2DM with OSA (*n*)No. of patients with T2DM without OSA (*n*)NOS gradeFan \[[@CR8]\]Prospective2015--2017121127BLee \[[@CR9]\]Prospective2007--20082121BLee \[[@CR10]\]Prospective2011--2014271284BLoo \[[@CR11]\]Prospective2011--201298BMeng \[[@CR12]\]OS20081911BNakashima \[[@CR13]\]OS2003--20094551BWu \[[@CR14]\]Retrospective2002--201210033BYumino \[[@CR15]\]OS2819BTotal no. of participants with T2DM (*n*)614554*OS* observational study, *T2DM* type 2 diabetes mellitus, *OSA* obstructive sleep apnea, *NOS* Newcastle Ottawa Scale

On the basis of the assessment by the NOS, a grade B was allotted to the studies indicating a moderate risk of bias as shown in Table [2](#Tab2){ref-type="table"}.

The baseline features of the studies are listed in Table [3](#Tab3){ref-type="table"}. According to the baseline features listed, the mean age of the participants ranged between 50.9 and 71.0 years. The majority of these patients with T2DM were male participants with an average percentage ranging from 66.7% to 98.4%. The mean percentages of participants with hypertension (49.2% to 79.2%), dyslipidemia (25.7% to 88.6%), and current smoker (16.7% to 63.6%) are also given in Table [3](#Tab3){ref-type="table"}.Table 3Baseline features of the participants with T2DM with versus without OSAStudiesAge (years)Male (%)HBP (%)DYS (%)CS (%)DM (%)OSA/NOSAOSA/NOSAOSA/NOSAOSA/NOSAOSA/NOSAOSA/NOSAFan \[[@CR8]\]57.7/57.284.9/80.368.2/63.626.6/25.750.1/50.9100/100Lee \[[@CR9]\]55.2/50.997.7/98.456.8/49.288.6/80.354.6/60.7100/100Lee \[[@CR10]\]59.0/57.588.1/82.968.0/54.060.1/58.735.4/35.6100/100Loo \[[@CR11]\]56.7/52.875.0/93.266.7/38.687.5/70.516.7/63.6100/100Meng \[[@CR12]\]66.5/66.870.7/66.775.7/79.268.9/66.736.5/31.3100/100Nakashima \[[@CR13]\]71.0/65.077.0/73.063.0/56.056.0/55.032.0/45.0100/100Wu \[[@CR14]\]55.0/55.084.2/83.273.8/70.544.6/40.024.6/23.2100/100Yumino \[[@CR15]\]66.0/65.084.0/68.078.0/79.084.0/53.063.0/58.0100/100*HBP* high blood pressure, *DYS* dyslipidemia, *CS* current smoker, *DM* diabetes mellitus, *OSA* obstructive sleep apnea, *NOSA* non-obstructive sleep apnea

Results of this Analysis {#Sec13}
------------------------

All patients with T2DM with or without OSA who underwent PCI were included. Our current analysis showed that MACEs (OR 2.28, 95% CI 1.24--4.18; *P* = 0.008) and all-cause mortality (OR 1.95, 95% CI 1.08--3.54; *P* = 0.03) were significantly higher in the OSA subgroup as shown in Fig. [2](#Fig2){ref-type="fig"}. However, MACCEs (OR 1.38, 95% CI 0.97--1.98; *P* = 0.07) and cardiac death (OR 1.79, 95% CI 0.77--4.16; *P* = 0.18) were not significantly different post PCI between these two subgroups of patients with T2DM with versus without OSA as shown in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Comparing the post-percutaneous coronary interventional outcomes in patients with T2DM with versus without obstructive sleep apnea (part I)

In addition, hospitalization for heart failure (OR 1.99, 95% CI 0.43--9.25; *P* = 0.38), re-infarction (OR 1.52, 95% CI 0.85--2.70; *P* = 0.16), stroke (OR 1.81, 95% CI 0.81--4.08; *P* = 0.15), TVR (OR 1.54, 95% CI 0.98--2.42; *P* = 0.06) and TLR (OR 1.32, 95% CI 0.80--2.18; *P* = 0.28) were also not significantly different post PCI as shown in Fig. [3](#Fig3){ref-type="fig"}.Fig. 3Comparing the post-percutaneous coronary interventional outcomes in patients with T2DM with versus without obstructive sleep apnea (part II)

Sensitivity analysis was carried out by an exclusion method whereby each study was excluded one by one and a new analysis was carried out each time and the new results were compared for any significant change compared to the main result of this analysis. However, consistent results were obtained throughout.

The funnel plot (Fig. [4](#Fig4){ref-type="fig"}) showed that there was no evidence of publication bias among the studies that were included to assess these cardiovascular outcomes post PCI in these patients with T2DM with versus without OSA.Fig. 4Funnel plot visually demonstrating no publication bias

A summary of the results is shown in Table [4](#Tab4){ref-type="table"}.Table 4Results of this analysisOutcomesOR with 95% CI*P* value*I*^2^ value (%)Major adverse cardiovascular and cerebrovascular events (MACCEs)1.38 \[0.97--1.98\]0.070Major adverse cardiac events (MACEs)2.28 \[1.24--4.18\]0.0080Cardiac death1.79 \[0.77--4.16\]0.180All-cause mortality1.95 \[1.08--3.54\]0.030Hospitalization for heart failure1.99 \[0.43--9.25\]0.380Re-infarction1.52 \[0.85--2.70\]0.160Stroke1.81 \[0.81--4.08\]0.150Target vessel revascularization (TVR)1.54 \[0.98--2.42\]0.060Target lesion revascularization (TLR)1.32 \[0.80--2.18\]0.280*OR* odds ratios, *CI* confidence intervals

Discussion {#Sec14}
==========

In a systematic review and meta-analysis which was published in 2012, the authors concluded that even though OSA appeared to be associated with stroke, the relationship between OSA and acute coronary syndrome or cardiovascular mortality would require further research \[[@CR16]\]. This current analysis focused on the post-interventional cardiovascular outcomes observed in patients with T2DM with versus without OSA.

Our results from this analysis have shown that in patients with T2DM, OSA was associated with a significantly higher all-cause mortality and MACEs following coronary angioplasty. However, the results for re-infarction, repeated revascularization, cardiac death, MACCEs, stroke, and re-hospitalization for heart failure were not significant.

The fact that MACEs were significantly higher in patients with T2DM and co-existing OSA whereas MACCEs were not significantly different following PCI might be explained by the all-cause mortality being significantly higher, thereby contributing to significantly higher MACEs whereas stroke was not significantly different between these two groups, rendering MACCEs non-significant.

OSA has been linked to cardiovascular events by several mechanisms \[[@CR17]\]. Studies have shown repeated cycles of intermittent hypoxemia, sympathetic activation, and sleep disruption as a result of OSA could lead to several vascular abnormalities such as endothelial dysfunction, vascular inflammation, and high platelet reactions \[[@CR18]\].

Similar to the results of this current study, another recently published meta-analysis based on the association of OSA with cardiovascular outcomes after PCI showed a significantly higher risk of MACEs and all-cause mortality associated with this intermittent hypoxemic disease \[[@CR19]\]. The authors concluded that patients with OSA had a greater risk of subsequent cardiovascular outcomes after PCI. They also stated that whether prevention of OSA might improve cardiovascular outcomes should further be investigated. A recent meta-analysis of prospective studies additionally showed that OSA apparently increased the risk of cardiac death, repeated revascularization, and non-fatal myocardial infarction after PCI \[[@CR20]\]. Nevertheless, the study dealt with the general population with coronary artery disease whereas our current paper was based on patients with T2DM with coronary artery disease.

In another study aimed at showing the clinical significance of OSA in patients with ACS in relation to diabetes status, OSA was associated with a higher risk of MACCEs at 1-year follow-up, following ACS in these patients with diabetes mellitus, but with different results in patients without diabetes mellitus \[[@CR21]\]. The study also showed that longer hypoxia in these patients with diabetes mellitus and OSA could further increase the risk of MACCEs to 31%. Similarly, among 168 consecutive patients who were admitted with unstable angina or non-ST elevation ACS, the authors suggested that OSA might represent an aggravating factor for such patients \[[@CR22]\].

Limitations {#Sec15}
-----------

This study has several limitations. Firstly, the total number of participants was small and this might have had an impact on the results and conclusion. Secondly, a few important cardiovascular outcomes including stent thrombosis were not assessed since they were not reported in the original studies, or were reported in only one study whereby a comparison was not possible. In addition, since the participants were on anticoagulants, bleeding outcomes would have also been interesting, but these outcomes were not reported in the original studies and therefore could not be analyzed in our paper. Another limitation could be the inclusion of data which were extracted from observational studies and could have contributed to the introduction of bias.

Conclusion {#Sec16}
==========

OSA was associated with a significant increase in all-cause mortality and MACEs post PCI in these patients with T2DM. Therefore, special care and continuous follow-up might be required for patients with T2DM with associated OSA following PCI. As a result of the limited number of participants, further larger studies would be required to confirm these hypotheses.
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